Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

43.0K
Overview
43.0K
Cancer Vaccines01:30

Cancer Vaccines

238
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
238
Cross-reactivity00:42

Cross-reactivity

30.9K
Overview
30.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of Novel Cloxyquin Analogs for K<sub>2P</sub>18.1 Channel Modulation.

Archiv der Pharmazie·2026
Same author

Brain age gap in multiple sclerosis: associated with disability but independent of serum biomarkers.

Therapeutic advances in neurological disorders·2026
Same author

Severe Immune-Related Neurological Adverse Events Associated With Immune Checkpoint Inhibitor Treatment: A Retrospective Single-Center Study.

European journal of neurology·2026
Same author

Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany, Austria, and Switzerland.

Therapeutic advances in neurological disorders·2026
Same author

Sex-Specific Differences in Amino Acids and Neurotransmitters in Multiple Sclerosis Patients Compared to Non-Neuroinflammatory Controls: A Retrospective Case-Control Study.

Neurochemical research·2026
Same author

Vestibular and Ocular Motor Phenotype in a Case of Paraneoplastic Autoimmune Kelch-Like Protein-11 Encephalitis.

Neurology(R) neuroimmunology & neuroinflammation·2026

Related Experiment Video

Updated: May 10, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.6K

SARS-CoV-2 Vaccines and Multiple Sclerosis: An Update.

Tobias Monschein1,2,3, Tobias Zrzavy1,2, Paulus S Rommer1,2

  • 1Department of Neurology, Medical University of Vienna, Austria.

Neurology(R) Neuroimmunology & Neuroinflammation
|April 25, 2025
PubMed
Summary

This review provides updated recommendations on COVID-19 vaccines for multiple sclerosis (MS) patients on disease-modifying therapies, covering vaccine efficacy, safety, and immune responses to SARS-CoV-2 variants.

More Related Videos

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

1.5K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

8.5K

Related Experiment Videos

Last Updated: May 10, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.6K
Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

1.5K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

8.5K

Area of Science:

  • Immunology
  • Neurology
  • Vaccinology

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, has led to a global health crisis with significant mortality.
  • Emerging SARS-CoV-2 variants, particularly Omicron sublines, have become dominant globally.
  • Understanding the immune response to SARS-CoV-2 vaccines in individuals with multiple sclerosis (MS) on disease-modifying therapies (DMTs) is crucial.

Purpose of the Study:

  • To provide an updated overview of COVID-19 vaccines for patients with multiple sclerosis (MS).
  • To offer recommendations for clinical practice concerning MS and SARS-CoV-2 vaccination.
  • To address vaccine efficacy, safety, SARS-CoV-2 variants, vaccine hesitancy, and immune response in MS patients on DMTs.

Main Methods:

  • This study is a review of existing literature and clinical data.
  • It synthesizes evidence on SARS-CoV-2 vaccine performance in the context of multiple sclerosis.
  • The review focuses on immune responses modulated by various disease-modifying therapies.

Main Results:

  • Evidence suggests varying immune responses to SARS-CoV-2 vaccines among MS patients on different DMTs.
  • Safety profiles of COVID-19 vaccines in MS populations require careful consideration.
  • The emergence of SARS-CoV-2 variants necessitates ongoing evaluation of vaccine effectiveness.

Conclusions:

  • Updated clinical recommendations are needed for optimizing COVID-19 vaccination strategies in MS patients.
  • Personalized approaches considering DMTs and individual immune responses are essential.
  • Further research is warranted to fully elucidate vaccine efficacy and long-term safety in this population.